Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Home
  • News
  • Articles
  • Exclusive
  • HB Originals
  • Gallery
  • Advertisement
  • Press Releases
Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
  • Medical Science
Search
  • Home
  • News
  • Articles
  • Exclusive
  • HB Originals
  • Gallery
  • Advertisement
  • Press Releases
Follow US
  • Advertise
© 2025 Health Hub Media Pvt Ltd. All Rights Reserved.
Healthcare Leadership, Policy & Digital Health News India > Blog > Frontline Focus > Zepto Partners with Orange Health for At-Home Tests

Zepto Partners with Orange Health for At-Home Tests

Published: November 24, 2025
SHARE

Quick-commerce giant Zepto is piloting a home-diagnostics service in partnership with Orange Health Labs, enabling users to book blood tests directly within the Zepto app with sample pickup in 60 minutes and report delivery within six hours.

Glimpse:

To boost repeat engagement and revenue per user, Zepto is expanding its healthcare vertical beyond medicine delivery. Its diagnostics service offers tests like CBC, thyroid function, and full-body checkups, all bookable on the app for doorstep sample collection.

Zepto, the Indian quick-commerce platform best known for its rapid grocery delivery, is making a bold move: it’s extending its pharmacy business to include at-home diagnostic tests.  The launch, currently in pilot mode in select cities, is part of Zepto’s strategy to deepen its presence in health and wellness. 

For this service, Zepto has partnered with Orange Health Labs, a diagnostics company focused on fast, decentralized testing. Users can book tests like complete blood count (CBC), thyroid panels, and comprehensive full-body screenings. According to Zepto, sample collection happens within approximately 60 minutes, and test reports are delivered digitally within six hours. 

The pricing of tests is also broad: basic tests such as fasting glucose may start as low as ~₹180, while ultra-comprehensive panels (after discounts) can go up to ₹11,999.  Zepto’s goal is to make diagnostics highly accessible and convenient, leveraging its existing app and logistics infrastructure to offer users value and stickiness beyond grocery purchases. 

By integrating diagnostics with its pharmacy vertical, Zepto is edging closer to becoming a one-stop healthcare app  blending delivery speed with meaningful health services, while tapping into a high-margin and recurring category.

“With Zepto Diagnostics, we’re not just delivering medicines we’re delivering health insights to your doorstep, for less time and more trust.”

By

HB Team

Related News

SwishX Launches Agentic AI Platform for Pharma and MedTech, Secures $2.2 Million Seed Funding

May 13, 2026

Sanofi India and NHM Madhya Pradesh Join Forces to Expand Rare Disease & NCD Care

May 11, 2026

NIPER Raebareli Partners with Lofty Laboratories to Accelerate Pharma Innovation in India

May 11, 2026

Genient Partners with AIT Biotech to Accelerate Clinical Genomics Expansion

May 5, 2026

Metropolis Introduces Breakthrough Blood Test for Early Alzheimer’s Detection

April 29, 2026

Cohance Lifesciences Bets Big on Leadership with Umang Vohra at the Helm

April 27, 2026

₹2,000 Cr Push to Turn Uttar Pradesh into India’s Next Pharma Manufacturing Hub

April 27, 2026

Quadria Capital Eyes ₹4,500 Cr Bet on Samarth Lifesciences

April 27, 2026

NIPER Hajipur & Boehringer Ingelheim Join Forces to Fast Track Drug Innovation

April 27, 2026

Sun Pharma’s $13 Billion Bet: A Bold Move to Dominate Global Pharma

April 24, 2026

Graviti Pharma Expands South India Footprint with Strategic Karnataka Entry

April 24, 2026

India–UK Biotech Corridor Launched to Power Next Wave of Life Sciences Innovation

April 23, 2026

Premji Invest Backs Newera Hospitals to Expand Advanced Care Beyond Metro Cities

April 23, 2026

Eli Lilly Strikes $7B Deal to Supercharge Next Gen Cancer Therapies

April 22, 2026

Venkaiah Naidu Unveils Atal MedTech Museum to Showcase India’s Healthcare Innovation Journey

April 23, 2026

Boehringer Ingelheim Launches £150M AI Hub in London to Accelerate Drug Discovery

April 23, 2026

Kotak Mahindra Bank Backs Advanced Diagnostics Upgrade at Mumbai’s Somaiya Hospital

April 23, 2026

Odisha Approves ₹3,877 Cr Investments to Accelerate Pharma and MedTech Growth

April 23, 2026

Siemens Healthineers Explores Karnataka Partnership to Build Future Ready HealthTech Hubs

April 18, 2026

Eli Lilly Eyes Kelonia Buyout to Accelerate Next Gen Cancer Therapies

April 20, 2026
Droplet DNA! AI + Microscopy Turns a Single Blood Droplet Into a Disease Test
Telangana Sees Steepest Drop in Births in 5 Years Push to Scrap Two-Child Rule for Elections
Sunil Mittal Highlights AI’s Transformative Potential for Healthcare and Medical Sciences
Hannah Joseph Hospital Files ₹42 Crore IPO Draft to Fuel Oncology & Tertiary Care Expansion
Metropolis Launches GLP-1 Test Packages to Safeguard Metabolic Health Amid Rise of Therapy Use
Your browser does not support the audio element.
Your browser does not support the audio element.

Contact us

Privacy Policy

Terms & Conditions

HealthBuzz is a leading platform for healthcare news in India, covering hospital leadership updates, health policy developments, digital health innovations, and emerging healthcare startups. Stay informed with the latest insights shaping India’s healthcare ecosystem.

Facebook Twitter Youtube Whatsapp

Quick Links

  • Home
  • Articles
  • HB Originals
  • News
  • Videos
  • Gallery

Company

  • About us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions

Install our Mobile App for Best Experience

Healthcare Leadership, Policy & Digital Health News IndiaHealthcare Leadership, Policy & Digital Health News India
Follow US
Health Hub Media Pvt. Ltd. © 2026 All Rights Reserved
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?